These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19747874)

  • 1. Hexosamine analogs: from metabolic glycoengineering to drug discovery.
    Wang Z; Du J; Che PL; Meledeo MA; Yarema KJ
    Curr Opin Chem Biol; 2009 Dec; 13(5-6):565-72. PubMed ID: 19747874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression.
    Aich U; Campbell CT; Elmouelhi N; Weier CA; Sampathkumar SG; Choi SS; Yarema KJ
    ACS Chem Biol; 2008 Apr; 3(4):230-40. PubMed ID: 18338853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
    Almaraz RT; Aich U; Khanna HS; Tan E; Bhattacharya R; Shah S; Yarema KJ
    Biotechnol Bioeng; 2012 Apr; 109(4):992-1006. PubMed ID: 22068462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid glycoengineering using N-acetylmannosamine and sialic acid analogs.
    Moons SJ; Adema GJ; Derks MT; Boltje TJ; Büll C
    Glycobiology; 2019 Jun; 29(6):433-445. PubMed ID: 30913290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.
    Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Potential of Norbornene-Modified Mannosamine Derivatives for Metabolic Glycoengineering.
    Späte AK; Dold JE; Batroff E; Schart VF; Wieland DE; Baudendistel OR; Wittmann V
    Chembiochem; 2016 Jul; 17(14):1374-83. PubMed ID: 27147502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides.
    Altmann S; Mut J; Wolf N; Meißner-Weigl J; Rudert M; Jakob F; Gutmann M; Lühmann T; Seibel J; Ebert R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialidases as regulators of bioengineered cellular surfaces.
    Zamora CY; Ryan MJ; d'Alarcao M; Kumar K
    Glycobiology; 2015 Jul; 25(7):784-91. PubMed ID: 25795684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.
    Mathew MP; Tan E; Labonte JW; Shah S; Saeui CT; Liu L; Bhattacharya R; Bovonratwet P; Gray JJ; Yarema KJ
    Chembiochem; 2017 Jul; 18(13):1204-1215. PubMed ID: 28218815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of non-natural ManNAc analogs for the expression of thiols on cell-surface sialic acids.
    Sampathkumar SG; Li AV; Yarema KJ
    Nat Protoc; 2006; 1(5):2377-85. PubMed ID: 17406481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery.
    Elmouelhi N; Aich U; Paruchuri VD; Meledeo MA; Campbell CT; Wang JJ; Srinivas R; Khanna HS; Yarema KJ
    J Med Chem; 2009 Apr; 52(8):2515-30. PubMed ID: 19326913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified
    Du J; Agatemor C; Saeui CT; Bhattacharya R; Jia X; Yarema KJ
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic glycoengineering: sialic acid and beyond.
    Du J; Meledeo MA; Wang Z; Khanna HS; Paruchuri VD; Yarema KJ
    Glycobiology; 2009 Dec; 19(12):1382-401. PubMed ID: 19675091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicomponent quantification of diastereomeric hexosamine monosaccharides using ion trap tandem mass spectrometry.
    Desaire H; Leary JA
    Anal Chem; 1999 Oct; 71(19):4142-7. PubMed ID: 10517139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hydrocortisone on the metabolic indices of hexosamine-containing biopolymers in the stomach].
    Sharaev PN; Ivanov VG; Kutiavin LI
    Farmakol Toksikol; 1988; 51(6):81-4. PubMed ID: 3234546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering.
    Saeui CT; Liu L; Urias E; Morrissette-McAlmon J; Bhattacharya R; Yarema KJ
    Mol Pharm; 2018 Mar; 15(3):705-720. PubMed ID: 28853901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directing evolution: the next revolution in drug discovery?
    Davis AM; Plowright AT; Valeur E
    Nat Rev Drug Discov; 2017 Oct; 16(10):681-698. PubMed ID: 28935911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach.
    Williams DE; Andersen RJ
    Nat Prod Rep; 2020 May; 37(5):617-633. PubMed ID: 31750842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioprospecting microbial natural product libraries from the marine environment for drug discovery.
    Liu X; Ashforth E; Ren B; Song F; Dai H; Liu M; Wang J; Xie Q; Zhang L
    J Antibiot (Tokyo); 2010 Aug; 63(8):415-22. PubMed ID: 20606699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venomics: a new paradigm for natural products-based drug discovery.
    Vetter I; Davis JL; Rash LD; Anangi R; Mobli M; Alewood PF; Lewis RJ; King GF
    Amino Acids; 2011 Jan; 40(1):15-28. PubMed ID: 20177945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.